haloperidol has been researched along with Anxiety in 99 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The ketamine challenge study in schizophrenia subjects is at the vortex of the current debate." | 9.09 | The schizophrenia ketamine challenge study debate. ( Carpenter, WT, 1999) |
| "In a 6-week placebo- and haloperidol (HAL)-controlled trial with 335 randomized subjects with chronic schizophrenia in an acute exacerbation, three fixed dose ranges of OLZ (5, 10, or 15 +/- 2." | 9.08 | A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. ( Beasley, CM; Sanger, TM; Tollefson, GD; Tran, PV, 1998) |
| "The purpose of this article was to report a case of chorea that developed in an elderly man being treated with gabapentin for severe anxiety." | 7.75 | Chorea associated with gabapentin use in an elderly man. ( Attupurath, R; Aziz, R; Muralee, S; Tampi, RR; Wollman, D, 2009) |
| "The anxiolytic effects of aniracetam have not been proven in animals despite its clinical usefulness for post-stroke anxiety." | 7.71 | Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. ( Kurasawa, M; Nakamura, K, 2001) |
| "A clinical comparison was made between a butyrophenone drug (haloperidol), and an established antianxiety agent of the benzodiazepine group (diazepam)." | 7.65 | Comparison of low doses of haloperidol and diazepam in anxiety states. ( Burrows, GD; Chiu, E; Stevenson, J, 1976) |
| " The aim of the present study was to analyze on a single case basis the relationship between a sudden increase in suicidality, anxiety symptoms, medication dosing and clinician- and patient-rated akathisia." | 6.77 | The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone. ( Bauer, M; Doucette, S; Lewitzka, U; Meyer, S; Möller, HJ; Musil, R; Riedel, M; Schennach, R; Seemüller, F, 2012) |
| "Catalepsy was induced by systemic haloperidol (0." | 5.56 | Low frequency deep brain stimulation in the inferior colliculus ameliorates haloperidol-induced catalepsy and reduces anxiety in rats. ( Ihme, H; Melo-Thomas, L; Schwarting, RKW, 2020) |
| "Malignant syndrome is a disease characterized by high fever, extrapyramidal syndrome and dysautonomia recognized during or at the time of stopping administration of antipsychotic medication and it is the most severe and lethal side effect of antipsychotic medication." | 5.30 | [A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine]. ( Fujimoto, K; Konishi, K; Kubota, M; Ogawa, H, 1997) |
| " In this post hoc analysis of the Brief Psychiatric Rating Scale anxiety-depression cluster, olanzapine therapy was associated with a significantly greater baseline-to-end-point improvement in the cluster compared with haloperidol therapy among 1996 randomized, double-blind subjects." | 5.09 | Anxious-depressive symptoms in schizophrenia: a new treatment target for pharmacotherapy? ( Sanger, TM; Tollefson, GD, 1999) |
| " The ketamine challenge study in schizophrenia subjects is at the vortex of the current debate." | 5.09 | The schizophrenia ketamine challenge study debate. ( Carpenter, WT, 1999) |
| "Cocaine cues significantly increased anxiety, ACTH, cortisol, and HVA." | 5.08 | Haloperidol antagonism of cue-elicited cocaine craving. ( Berger, SP; Carr, K; Crawford, CA; Delucchi, K; Hall, S; Mickalian, JD; Reid, MS, 1996) |
| "The subjects were 62 patients hospitalized for acute exacerbations of schizophrenia and were randomly assigned to receive risperidone (mean dose, 7." | 5.08 | Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients. ( Azorin, JM; Blin, O; Bouhours, P, 1996) |
| "In a 6-week placebo- and haloperidol (HAL)-controlled trial with 335 randomized subjects with chronic schizophrenia in an acute exacerbation, three fixed dose ranges of OLZ (5, 10, or 15 +/- 2." | 5.08 | A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. ( Beasley, CM; Sanger, TM; Tollefson, GD; Tran, PV, 1998) |
| "To establish the differential indication of trazodone and to find the predictors of its efficacy, we conducted a study in which 45 patients with major depressive disorder and 75 patients with acute schizophrenia were randomly assigned under double-blind conditions to either 400 mg trazodone daily, 150 mg amitriptyline daily, 20 mg haloperidol daily, or placebo daily." | 5.06 | Experimental examination of trazodone. ( Klieser, E; Lehmann, E, 1989) |
| "The results suggest alcohol-induced locomotor hyperactivity in zebrafish is mediated via activation of dopamine D2-like receptors, whereas anxiety-like behavioral responses may only be altered by a high haloperidol concentration, at which dose the drug may affect receptors other than D2-R." | 3.83 | Alcohol-induced behavioral changes in zebrafish: The role of dopamine D2-like receptors. ( Facciol, A; Gerlai, R; Tran, S, 2016) |
| "The World Health Organization recommends that anxiety, depression, agitation and delirium at end of life should be treated with drugs such as lorazepam, diazepam, midazolam and haloperidol." | 3.83 | Look again at psychedelic drugs. ( Cameron, R, 2016) |
| "The purpose of this article was to report a case of chorea that developed in an elderly man being treated with gabapentin for severe anxiety." | 3.75 | Chorea associated with gabapentin use in an elderly man. ( Attupurath, R; Aziz, R; Muralee, S; Tampi, RR; Wollman, D, 2009) |
| "Mice were treated once with 50 or 100 mg/kg of the essential oil, intraperitoneally, 30 min before being submitted to behavioural models of: locomotor activity (open-field), catalepsy, anxiety (elevated plus maze), depression (forced swimming test and tail suspension tests) as well as apomorphine-induced stereotypy." | 3.75 | Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice. ( de Araújo, FY; de Moraes, MO; de Oliveira, GV; de Sousa, FC; Leal, LK; Macêdo, DS; Moura, BA; Silva, MI; Vasconcelos, SM; Viana, GS, 2009) |
| "The anxiolytic effects of aniracetam have not been proven in animals despite its clinical usefulness for post-stroke anxiety." | 3.71 | Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. ( Kurasawa, M; Nakamura, K, 2001) |
| "Buspirone is renowned for its highly inconsistent effects in animal models of anxiety." | 3.69 | Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. ( Cole, JC; Rodgers, RJ, 1994) |
| "To study a correlation between anxiety and delirium, 50 schizophrenic patients with the anxiety-delirious syndrome were treated with anxiolytics (leponex and phenazepam)." | 3.67 | [Structure of the anxious-delusional syndrome of schizophrenic patients during treatment with anxiolytics]. ( Nuller, IuL; Vasil'ev, AA, 1986) |
| " The aim of the present study was to analyze on a single case basis the relationship between a sudden increase in suicidality, anxiety symptoms, medication dosing and clinician- and patient-rated akathisia." | 2.77 | The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone. ( Bauer, M; Doucette, S; Lewitzka, U; Meyer, S; Möller, HJ; Musil, R; Riedel, M; Schennach, R; Seemüller, F, 2012) |
| "Catalepsy was induced by systemic haloperidol (0." | 1.56 | Low frequency deep brain stimulation in the inferior colliculus ameliorates haloperidol-induced catalepsy and reduces anxiety in rats. ( Ihme, H; Melo-Thomas, L; Schwarting, RKW, 2020) |
| "Triadimefon (TDF) is a triazole fungicide extensively used in agriculture that has been found as a pollutant in numerous water sources." | 1.51 | Behavioral effects of triadimefon in zebrafish are associated with alterations of the dopaminergic and serotonergic pathways. ( Alcayaga, J; Allende, ML; De la Paz, JF; Paredes-Zúñiga, S; Trost, N, 2019) |
| "Pretreatment with atropine, phenoxybenzamine, propranolol and bicuculline did not influence the action of PACAP-38 on the time spent in open arms." | 1.42 | Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats. ( Adamik, A; Telegdy, G, 2015) |
| "Haloperidol is a dopamine D2 receptor antagonist that induces catalepsy when systemically administered to rodents." | 1.39 | Dopaminergic mechanisms underlying catalepsy, fear and anxiety: do they interact? ( Brandão, ML; Colombo, AC; de Oliveira, AR; Reimer, AE, 2013) |
| "Hyperventilation syndrome has often occurred as a reaction to anxiety and stress." | 1.35 | [Hyperventilation syndrome before induction of and after awakening from general anesthesia]. ( Hanaoka, K; Honda, M; Itou, Y; Mizuno, J; Momoeda, K; Morita, S, 2009) |
| "All four of the reviewed cases with myokymia of the shoulders were intubated and none without it were intubated." | 1.35 | Fasciculations after rattlesnake envenomations: a retrospective statewide poison control system study. ( Cantrell, FL; Vohra, R; Williams, SR, 2008) |
| " Compound 16g also shows good oral bioavailability (59%) and exhibits a brain/plasma ratio of 2." | 1.34 | Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key fragments of HTS hits. ( Andersen, K; Chen, CA; Craig, DA; Daniewska, I; Forray, C; Hegde, LG; Jiang, Y; Kong, R; Li, B; Lu, K; Marzabadi, MR; Mazza, CG; Negron, L; Parola, T; Wetzel, JM; Wolinsky, TD, 2007) |
| "Haloperidol treatment produced VCM in 40% of the treated rats and the concomitant treatment with V." | 1.34 | Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter. ( Avila, DS; Burger, ME; Calixto, JB; Fachinetto, R; Ferreira, J; Pereira, RP; Rocha, JB; Villarinho, JG; Wagner, C, 2007) |
| "Malignant syndrome is a disease characterized by high fever, extrapyramidal syndrome and dysautonomia recognized during or at the time of stopping administration of antipsychotic medication and it is the most severe and lethal side effect of antipsychotic medication." | 1.30 | [A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine]. ( Fujimoto, K; Konishi, K; Kubota, M; Ogawa, H, 1997) |
| "To describe a case of possible toxic encephalopathy in a surgical patient receiving high-dose intravenous haloperidol." | 1.30 | Possible toxic encephalopathy following high-dose intravenous haloperidol. ( Maxa, JL; Ogu, CC; Taleghani, AM; Tanzi, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (39.39) | 18.7374 |
| 1990's | 15 (15.15) | 18.2507 |
| 2000's | 22 (22.22) | 29.6817 |
| 2010's | 19 (19.19) | 24.3611 |
| 2020's | 4 (4.04) | 2.80 |
| Authors | Studies |
|---|---|
| Lages, YV | 1 |
| Maisonnette, SS | 1 |
| Rosseti, FP | 1 |
| Galvão, BO | 1 |
| Landeira-Fernandez, J | 1 |
| Osacka, J | 1 |
| Kiss, A | 1 |
| Mach, M | 1 |
| Tillinger, A | 1 |
| Koprdova, R | 1 |
| Ihme, H | 1 |
| Schwarting, RKW | 1 |
| Melo-Thomas, L | 1 |
| Scudamore, T | 1 |
| Liem, A | 1 |
| Wiener, M | 1 |
| Ekure, NS | 1 |
| Botash, C | 1 |
| Empey, D | 1 |
| Leontieva, L | 1 |
| Onaolapo, OJ | 1 |
| Paul, TB | 1 |
| Onaolapo, AY | 1 |
| Pértile, RAN | 1 |
| Corvino, ME | 1 |
| Marchette, RCN | 1 |
| Pavesi, E | 1 |
| Cavalli, J | 1 |
| Ramos, A | 1 |
| Izídio, GS | 1 |
| Paredes-Zúñiga, S | 1 |
| Trost, N | 1 |
| De la Paz, JF | 1 |
| Alcayaga, J | 1 |
| Allende, ML | 1 |
| Akhlaghi, N | 1 |
| Payandemehr, P | 1 |
| Yaseri, M | 1 |
| Akhlaghi, AA | 1 |
| Abdolrazaghnejad, A | 1 |
| Telegdy, G | 8 |
| Adamik, A | 3 |
| Colombo, AC | 1 |
| de Oliveira, AR | 1 |
| Reimer, AE | 1 |
| Brandão, ML | 1 |
| Jászberényi, M | 3 |
| Palotai, M | 3 |
| Tanaka, M | 1 |
| Bagosi, Z | 1 |
| Yang, Y | 1 |
| Qin, J | 1 |
| Chen, W | 1 |
| Sui, N | 1 |
| Chen, H | 1 |
| Li, M | 1 |
| Tran, S | 1 |
| Facciol, A | 1 |
| Gerlai, R | 1 |
| Cameron, R | 1 |
| Samad, N | 1 |
| Haleem, MA | 1 |
| Haleem, DJ | 1 |
| Wegener, N | 1 |
| Koch, M | 1 |
| Mizuno, J | 1 |
| Morita, S | 1 |
| Itou, Y | 1 |
| Honda, M | 1 |
| Momoeda, K | 1 |
| Hanaoka, K | 1 |
| Attupurath, R | 1 |
| Aziz, R | 1 |
| Wollman, D | 1 |
| Muralee, S | 1 |
| Tampi, RR | 1 |
| de Araújo, FY | 1 |
| Silva, MI | 1 |
| Moura, BA | 1 |
| de Oliveira, GV | 1 |
| Leal, LK | 1 |
| Vasconcelos, SM | 1 |
| Viana, GS | 1 |
| de Moraes, MO | 1 |
| de Sousa, FC | 1 |
| Macêdo, DS | 1 |
| Paterson, NE | 1 |
| Hanania, T | 1 |
| Savio, LE | 1 |
| Vuaden, FC | 1 |
| Piato, AL | 1 |
| Bonan, CD | 1 |
| Wyse, AT | 1 |
| Joshi, M | 1 |
| Akhtar, M | 1 |
| Najmi, AK | 1 |
| Khuroo, AH | 1 |
| Goswami, D | 1 |
| Seemüller, F | 1 |
| Lewitzka, U | 1 |
| Bauer, M | 1 |
| Meyer, S | 1 |
| Musil, R | 1 |
| Schennach, R | 1 |
| Riedel, M | 1 |
| Doucette, S | 1 |
| Möller, HJ | 1 |
| Ukai, M | 1 |
| Mitsunaga, H | 1 |
| Espinosa-Avilés, D | 1 |
| Elizondo, G | 1 |
| Morales-Martínez, M | 1 |
| Rodríguez-Herrejón, F | 1 |
| Varela, P | 1 |
| Pereira, M | 1 |
| Uriarte, N | 1 |
| Agrati, D | 1 |
| Zuluaga, MJ | 1 |
| Ferreira, A | 1 |
| Pogorelov, VM | 1 |
| Rodriguiz, RM | 1 |
| Insco, ML | 1 |
| Caron, MG | 1 |
| Wetsel, WC | 1 |
| Inoue, T | 1 |
| Izumi, T | 1 |
| Li, XB | 1 |
| Kitaichi, Y | 1 |
| Nakagawa, S | 1 |
| Koyama, T | 1 |
| Overstreet, DH | 1 |
| Knapp, DJ | 1 |
| Breese, GR | 1 |
| Chen, CA | 1 |
| Jiang, Y | 1 |
| Lu, K | 1 |
| Daniewska, I | 1 |
| Mazza, CG | 1 |
| Negron, L | 1 |
| Forray, C | 1 |
| Parola, T | 1 |
| Li, B | 1 |
| Hegde, LG | 1 |
| Wolinsky, TD | 1 |
| Craig, DA | 1 |
| Kong, R | 1 |
| Wetzel, JM | 1 |
| Andersen, K | 1 |
| Marzabadi, MR | 1 |
| Fachinetto, R | 1 |
| Villarinho, JG | 1 |
| Wagner, C | 1 |
| Pereira, RP | 1 |
| Avila, DS | 1 |
| Burger, ME | 1 |
| Calixto, JB | 1 |
| Rocha, JB | 1 |
| Ferreira, J | 1 |
| Vohra, R | 1 |
| Cantrell, FL | 1 |
| Williams, SR | 1 |
| Johnstone, M | 1 |
| Yoshimura, H | 1 |
| Ogawa, N | 1 |
| Jenkins, RL | 1 |
| Ashby, HB | 1 |
| Shearman, GT | 1 |
| Lal, H | 1 |
| Janner, D | 1 |
| Cole, JC | 1 |
| Rodgers, RJ | 1 |
| Simon, P | 1 |
| Panissaud, C | 1 |
| Costentin, J | 1 |
| Rasmussen, K | 1 |
| Berger, SP | 1 |
| Hall, S | 2 |
| Mickalian, JD | 1 |
| Reid, MS | 1 |
| Crawford, CA | 1 |
| Delucchi, K | 1 |
| Carr, K | 1 |
| Blin, O | 1 |
| Azorin, JM | 1 |
| Bouhours, P | 1 |
| Konishi, K | 1 |
| Fujimoto, K | 1 |
| Kubota, M | 1 |
| Ogawa, H | 1 |
| Maxa, JL | 1 |
| Taleghani, AM | 1 |
| Ogu, CC | 1 |
| Tanzi, M | 1 |
| Biró, E | 1 |
| Penke, B | 1 |
| Singh, Y | 1 |
| Jaiswal, AK | 1 |
| Singh, M | 1 |
| Bhattacharya, SK | 1 |
| Tollefson, GD | 2 |
| Sanger, TM | 2 |
| Beasley, CM | 1 |
| Tran, PV | 1 |
| Carpenter, WT | 1 |
| Hurford, WE | 1 |
| Kehne, JH | 1 |
| Coverdale, S | 1 |
| McCloskey, TC | 1 |
| Hoffman, DC | 1 |
| Cassella, JV | 1 |
| Liechti, ME | 1 |
| Vollenweider, FX | 1 |
| Wang, Y | 1 |
| Xu, R | 1 |
| Sasaoka, T | 1 |
| Tonegawa, S | 1 |
| Kung, MP | 1 |
| Sankoorikal, EB | 1 |
| Yao, JK | 1 |
| Reddy, R | 1 |
| van Kammen, DP | 1 |
| Nakamura, K | 1 |
| Kurasawa, M | 1 |
| Cancela, LM | 1 |
| Basso, AM | 1 |
| Martijena, ID | 1 |
| Capriles, NR | 1 |
| Molina, VA | 1 |
| Suzuki, A | 1 |
| Kondo, T | 1 |
| Mihara, K | 1 |
| Yasui-Furukori, N | 1 |
| Ishida, M | 1 |
| Furukori, H | 1 |
| Kaneko, S | 1 |
| Inoue, Y | 1 |
| Otani, K | 1 |
| Pretorius, JL | 1 |
| Phillips, M | 1 |
| Langley, RW | 1 |
| Szabadi, E | 1 |
| Bradshaw, CM | 1 |
| Heath, A | 1 |
| Singh, MM | 4 |
| Kay, SR | 2 |
| Budden, MG | 1 |
| Blaha, L | 1 |
| Zenglein, R | 1 |
| Wiedmayer, J | 1 |
| Gilbert, GJ | 1 |
| Gomez, J | 1 |
| Dally, P | 1 |
| Thornton, WE | 1 |
| Stevenson, J | 1 |
| Burrows, GD | 1 |
| Chiu, E | 1 |
| Nisijima, K | 1 |
| Hirayama, M | 1 |
| Borsini, F | 1 |
| Lecci, A | 1 |
| Volterra, G | 1 |
| Meli, A | 1 |
| Klieser, E | 1 |
| Lehmann, E | 1 |
| Vasil'ev, AA | 1 |
| Nuller, IuL | 1 |
| Russell, KH | 1 |
| Hagenmeyer-Houser, SH | 1 |
| Sanberg, PR | 1 |
| Venning, M | 1 |
| Rogers, J | 1 |
| Ananth, J | 1 |
| Walsh, AC | 1 |
| Walsh, BH | 1 |
| de Groot, MH | 1 |
| Bainbridge, JG | 1 |
| Greenwood, DT | 1 |
| James, B | 2 |
| James, NM | 2 |
| Di Scipio, WJ | 1 |
| Lord, DJ | 1 |
| Kidd, CB | 1 |
| Kenway, AK | 1 |
| Quinn, PT | 2 |
| Peachey, EC | 1 |
| Guz, I | 1 |
| Moraes, R | 1 |
| Sartoretto, JN | 1 |
| Peachey, C | 1 |
| Donald, JF | 1 |
| Rogerson, R | 1 |
| Butler, JK | 1 |
| Gilbert, MM | 1 |
| Winkelman, NW | 1 |
| Faretra, G | 1 |
| Dooher, L | 1 |
| Dowling, J | 1 |
| Lichko, AE | 1 |
| Marchenko, BV | 1 |
| Prakhov, VI | 1 |
| Radavichius, LI | 1 |
| Khaliavin, AV | 1 |
| Fiume, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Mindful Melody: Feasibility of Implementing Music Listening on an Inpatient Psychiatric Unit and Its Relation to the Use of As Needed Medications for Acute Agitation[NCT04514432] | 172 participants (Actual) | Observational | 2018-08-16 | Completed | |||
| A Comparison of Midazolam or Haloperidol Premedication Versus Placebo for Reducing Ketamine Induced Agitation After Adult Procedural Sedation in the Emergency Department[NCT02909465] | Phase 4 | 185 participants (Actual) | Interventional | 2016-07-31 | Completed | ||
| Positive Imagery Therapy and the Incidence of Emergence Reactions With the Use of Ketamine[NCT04746079] | 180 participants (Anticipated) | Interventional | 2021-02-05 | Recruiting | |||
| Effect of Clonidine on Responses to Imagery Scripts[NCT00318760] | Phase 1 | 92 participants (Actual) | Interventional | 2005-06-14 | Completed | ||
| Effects of Propranolol on Responses to Drug-Related Imagery Scripts[NCT00688805] | Phase 1 | 40 participants (Actual) | Interventional | 2007-12-12 | Terminated | ||
| PET Assays of Striatal Dopamine Markers in Cocaine Craving[NCT01036516] | 14 participants (Anticipated) | Observational | 1998-06-23 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for haloperidol and Anxiety
| Article | Year |
|---|---|
CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons.
Topics: Animals; Anxiety; Brain; Cholecystokinin; Dopamine; Haloperidol; Humans; Neurons; Pyrazoles; Recepto | 1994 |
Psychiatric drug treatment in children.
Topics: Adolescent; Amphetamines; Antipsychotic Agents; Anxiety; Autistic Disorder; Behavior Therapy; Child; | 1979 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
25 trials available for haloperidol and Anxiety
| Article | Year |
|---|---|
Premedication With Midazolam or Haloperidol to Prevent Recovery Agitation in Adults Undergoing Procedural Sedation With Ketamine: A Randomized Double-Blind Clinical Trial.
Topics: Administration, Intravenous; Adult; Anxiety; Conscious Sedation; Double-Blind Method; Emergency Serv | 2019 |
Premedication With Midazolam or Haloperidol to Prevent Recovery Agitation in Adults Undergoing Procedural Sedation With Ketamine: A Randomized Double-Blind Clinical Trial.
Topics: Administration, Intravenous; Adult; Anxiety; Conscious Sedation; Double-Blind Method; Emergency Serv | 2019 |
Premedication With Midazolam or Haloperidol to Prevent Recovery Agitation in Adults Undergoing Procedural Sedation With Ketamine: A Randomized Double-Blind Clinical Trial.
Topics: Administration, Intravenous; Adult; Anxiety; Conscious Sedation; Double-Blind Method; Emergency Serv | 2019 |
Premedication With Midazolam or Haloperidol to Prevent Recovery Agitation in Adults Undergoing Procedural Sedation With Ketamine: A Randomized Double-Blind Clinical Trial.
Topics: Administration, Intravenous; Adult; Anxiety; Conscious Sedation; Double-Blind Method; Emergency Serv | 2019 |
The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone.
Topics: Adolescent; Adult; Age Factors; Akathisia, Drug-Induced; Antipsychotic Agents; Anxiety; Female; Halo | 2012 |
The effects of sedation on the digital plethysmogram. A radiotelemetric study of haloperidol.
Topics: Adolescent; Adult; Anxiety; Blood Vessels; Drug Antagonism; Drug Synergism; Female; Fingers; Haloper | 1967 |
Haloperidol antagonism of cue-elicited cocaine craving.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Anxiety; Cocaine; Conditioning, Psychological; Cross | 1996 |
Haloperidol antagonism of cue-elicited cocaine craving.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Anxiety; Cocaine; Conditioning, Psychological; Cross | 1996 |
Haloperidol antagonism of cue-elicited cocaine craving.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Anxiety; Cocaine; Conditioning, Psychological; Cross | 1996 |
Haloperidol antagonism of cue-elicited cocaine craving.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Anxiety; Cocaine; Conditioning, Psychological; Cross | 1996 |
Haloperidol antagonism of cue-elicited cocaine craving.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Anxiety; Cocaine; Conditioning, Psychological; Cross | 1996 |
Haloperidol antagonism of cue-elicited cocaine craving.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Anxiety; Cocaine; Conditioning, Psychological; Cross | 1996 |
Haloperidol antagonism of cue-elicited cocaine craving.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Anxiety; Cocaine; Conditioning, Psychological; Cross | 1996 |
Haloperidol antagonism of cue-elicited cocaine craving.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Anxiety; Cocaine; Conditioning, Psychological; Cross | 1996 |
Haloperidol antagonism of cue-elicited cocaine craving.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Anxiety; Cocaine; Conditioning, Psychological; Cross | 1996 |
Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Double-Blind Method; Drug The | 1996 |
A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia.
Topics: Adult; Antipsychotic Agents; Anxiety; Benzodiazepines; Depression; Dose-Response Relationship, Drug; | 1998 |
Anxious-depressive symptoms in schizophrenia: a new treatment target for pharmacotherapy?
Topics: Antipsychotic Agents; Anxiety; Benzodiazepines; Brief Psychiatric Rating Scale; Depression; Double-B | 1999 |
The schizophrenia ketamine challenge study debate.
Topics: Anesthetics, Dissociative; Anxiety; Bioethics; Brief Psychiatric Rating Scale; Consumer Product Safe | 1999 |
Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans.
Topics: Adult; Affect; Antipsychotic Agents; Anxiety; Blood Pressure; Body Temperature; Consciousness; Dopam | 2000 |
Comparison of clozapine and haloperidol on some autonomic and psychomotor functions, and on serum prolactin concentration, in healthy subjects.
Topics: Adult; Antipsychotic Agents; Anxiety; Attention; Autonomic Nervous System; Blood Pressure; Clozapine | 2001 |
A comparative study of haloperidol and diazepam in the treatment of anxiety.
Topics: Adult; Aged; Anxiety; Clinical Trials as Topic; Diazepam; Female; Haloperidol; Humans; Male; Middle | 1979 |
[Therapy of acute schizophrenic attacks. High dosage haloperidol therapy compared with a two component treatment].
Topics: Anxiety; Attention; Basal Ganglia Diseases; Drug Therapy, Combination; Haloperidol; Humans; Memory; | 1979 |
Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
Topics: Adult; Anxiety; Chlorpromazine; Clinical Trials as Topic; Female; Haloperidol; Humans; Longitudinal | 1976 |
A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
Topics: Adult; Affect; Anxiety; Basal Ganglia Diseases; Benztropine; Chlorpromazine; Clinical Trials as Topi | 1975 |
Experimental examination of trazodone.
Topics: Adult; Amitriptyline; Anxiety; Depression; Depressive Disorder; Double-Blind Method; Female; Haloper | 1989 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
Low dosage haloperidol and induced anxiety in normal volunteers.
Topics: Anxiety; Chlordiazepoxide; Female; Haloperidol; Humans; Male; Placebos; Pulse | 1973 |
Changes in staff anxiety and attitudes during a double blind study of haloperidol in acute schizophrenics within a structured milieu.
Topics: Antiparkinson Agents; Anxiety; Attitude of Health Personnel; Benztropine; Clinical Trials as Topic; | 1972 |
Tranquilizers and examination stress.
Topics: Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Educational Measurement; Female; Haloperidol; H | 1973 |
Haloperidol versus diazepam: a double-blind crossover clinical trial.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anxiety; Clinical Trials as Topic; Diazepam; Female; | 1973 |
A double-blind comparison of pimozide and haloperidol in the treatment of recurrent anxiety states.
Topics: Adult; Anxiety; Clinical Trials as Topic; Female; Haloperidol; Humans; Male; Middle Aged; Pimozide; | 1973 |
Haloperidol in the treatment of stutterers.
Topics: Anxiety; Clinical Trials as Topic; Haloperidol; Humans; Stuttering | 1973 |
The therapeutic effects of lorazepam in psychotic patients treated with haloperidol: a double-blind study.
Topics: Adult; Anxiety; Behavior; Benzazepines; Clinical Trials as Topic; Drug Interactions; Haloperidol; Hu | 1972 |
A study of a recognized antipsychotic agent as a tranquilizer in general practice.
Topics: Adolescent; Adult; Aged; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Family Practice; Femal | 1969 |
Assessment of low dosage haloperidol in anxiety states.
Topics: Adult; Aged; Anxiety; Clinical Trials as Topic; Depression; Female; Haloperidol; Humans; Male; Middl | 1971 |
72 other studies available for haloperidol and Anxiety
| Article | Year |
|---|---|
Haloperidol and methylphenidate alter motor behavior and responses to conditioned fear of Carioca Low-conditioned Freezing rats.
Topics: Animals; Anxiety; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Conditioning, Psy | 2021 |
Haloperidol and aripiprazole affects CRH system and behaviour of animals exposed to chronic mild stress.
Topics: Amygdala; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Corticotropin-Rele | 2022 |
Low frequency deep brain stimulation in the inferior colliculus ameliorates haloperidol-induced catalepsy and reduces anxiety in rats.
Topics: Animals; Anxiety; Catalepsy; Deep Brain Stimulation; Disease Models, Animal; Haloperidol; Male; Rats | 2020 |
Mindful Melody: feasibility of implementing music listening on an inpatient psychiatric unit and its relation to the use of as needed medications for acute agitation.
Topics: Anxiety; Feasibility Studies; Haloperidol; Humans; Inpatients; Music; Psychomotor Agitation | 2021 |
Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Anxiety; Behavior, Animal; Benzodiazepines; Do | 2017 |
The Quinpirole Hypolocomotive Effects are Strain and Route of Administration Dependent in SHR and SLA16 Isogenic Rats.
Topics: Animals; Anxiety; Behavior, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Drug Administration | 2017 |
Behavioral effects of triadimefon in zebrafish are associated with alterations of the dopaminergic and serotonergic pathways.
Topics: Aggression; Animals; Anxiety; Behavior, Animal; Benzazepines; Dopamine; Dopamine Antagonists; Dose-R | 2019 |
Involvement of transmitters in the anxiolytic action of urocortin 3 in mice.
Topics: Analysis of Variance; Animals; Anxiety; Atropine; Bicuculline; Disease Models, Animal; Dose-Response | 2013 |
Anxiolytic action of neuromedin-U and neurotransmitters involved in mice.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anxiety; At | 2013 |
Dopaminergic mechanisms underlying catalepsy, fear and anxiety: do they interact?
Topics: Analysis of Variance; Animals; Anxiety; Catalepsy; Conditioning, Classical; Dopamine; Dopamine Antag | 2013 |
Transmitter mediation of the anxiolytic action of apelin-13 in male mice.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anxiety; Atropine; Bicuculline; | 2014 |
Orexin A-induced anxiety-like behavior is mediated through GABA-ergic, α- and β-adrenergic neurotransmissions in mice.
Topics: Animals; Anxiety; Atropine; Behavior, Animal; Bicuculline; gamma-Aminobutyric Acid; Haloperidol; Int | 2014 |
Neuropeptide AF induces anxiety-like and antidepressant-like behavior in mice.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agent | 2014 |
Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats.
Topics: Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Anxiety; Arginine; Atropine; Bicuculli | 2015 |
Behavioral and pharmacological investigation of anxiety and maternal responsiveness of postpartum female rats in a pup elevated plus maze.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Dopamine D2 Receptor Antagonists; Female; Fluoxetin | 2015 |
Alcohol-induced behavioral changes in zebrafish: The role of dopamine D2-like receptors.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Central Nervous System Depressants; Dopamin | 2016 |
Anxiolytic effect of the GPR103 receptor agonist peptide P550 (homolog of neuropeptide 26RFa) in mice. Involvement of neurotransmitters.
Topics: Animals; Anxiety; Atropine; Bicuculline; Cyproheptadine; Haloperidol; Methysergide; Mice; Neuropepti | 2016 |
Look again at psychedelic drugs.
Topics: Anxiety; Delirium; Depression; Diazepam; Hallucinogens; Haloperidol; Humans; Lorazepam; Midazolam; P | 2016 |
Behavioral effects of 1-(m-chlorophenyl)piperazine (m-CPP) in a rat model of tardive dyskinesia.
Topics: Animals; Anxiety; Behavior, Animal; Disease Models, Animal; Dopamine Antagonists; Dyskinesia, Drug-I | 2008 |
Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
Topics: Aging; Animals; Anxiety; Apomorphine; Behavior, Animal; Benzoxazines; Brain; Cannabinoids; Dopamine | 2009 |
[Hyperventilation syndrome before induction of and after awakening from general anesthesia].
Topics: Anesthesia, Epidural; Anesthesia, General; Antipsychotic Agents; Anxiety; Arthroplasty, Replacement, | 2009 |
Chorea associated with gabapentin use in an elderly man.
Topics: Aged; Amines; Analgesics; Anti-Dyskinesia Agents; Anxiety; Chorea; Cognition Disorders; Cyclohexanec | 2009 |
Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice.
Topics: Alpinia; Animals; Antipsychotic Agents; Anxiety; Apomorphine; Behavior, Animal; Catalepsy; Central N | 2009 |
The modified Geller-Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Behavior, Animal; Conditioning, Operant; C | 2010 |
Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish.
Topics: 1-Pyrroline-5-Carboxylate Dehydrogenase; Amino Acid Metabolism, Inborn Errors; Animals; Antipsychoti | 2012 |
Effect of zinc in animal models of anxiety, depression and psychosis.
Topics: Animals; Anxiety; Behavior, Animal; Central Nervous System Agents; Chlorides; Depression; Disease Mo | 2012 |
Tail-swing behavior: a novel animal model for anxiety.
Topics: Animals; Anxiety; Behavior, Animal; Desipramine; Diazepam; Disease Models, Animal; Haloperidol; Immo | 2003 |
Treatment of acute self-aggressive behaviour in a captive gorilla (Gorilla gorilla gorilla).
Topics: Aggression; Animals; Antipsychotic Agents; Anxiety; Ape Diseases; Female; Gorilla gorilla; Haloperid | 2004 |
Motivational aspects of maternal anxiolysis in lactating rats.
Topics: Animals; Anxiety; Female; Haloperidol; Lactation; Maternal Behavior; Maze Learning; Motivation; Preg | 2005 |
Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene.
Topics: Animals; Anxiety; Behavior, Animal; Biogenic Monoamines; Brain Chemistry; Chi-Square Distribution; D | 2005 |
Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear.
Topics: Analysis of Variance; Animals; Anxiety; Behavior, Animal; Benzazepines; Conditioning, Psychological; | 2005 |
Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.
Topics: Alcohol Drinking; Aminopyridines; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodiaz | 2007 |
Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key fragments of HTS hits.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Biological Availability; Brain; Cell Line; Cytoskeletal Prote | 2007 |
Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter.
Topics: Animals; Antipsychotic Agents; Anxiety; Behavior, Animal; Brain Chemistry; Dopamine; Dopamine Antago | 2007 |
Fasciculations after rattlesnake envenomations: a retrospective statewide poison control system study.
Topics: Adolescent; Adult; Animals; Antivenins; Anxiety; California; Child; Child, Preschool; Crotalus; Data | 2008 |
[Pharmaco-ethological analysis of agonistic behavior between resident and intruder mice: effects of psychotropic drugs].
Topics: Aggression; Agonistic Behavior; Animals; Anxiety; Chlordiazepoxide; Female; Haloperidol; Hostility; | 1984 |
Gilles de la Tourette's syndrome in identical twins.
Topics: Adolescent; Anxiety; Diseases in Twins; Female; Genetics, Behavioral; Haloperidol; Humans; Male; Pho | 1983 |
Discriminative stimulus properties of cocaine related to an anxiogenic action.
Topics: Animals; Anxiety; Cocaine; Diazepam; Discrimination, Psychological; Haloperidol; Humans; Male; Penty | 1981 |
Anxiety, insomnia and movement disorder in a fifteen-year-old hispanic female.
Topics: Adolescent; Anxiety; Chorea; Female; Haloperidol; Humans; Penicillins; Rheumatic Fever; Sleep Initia | 1995 |
Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.
Topics: Animals; Anxiety; Behavior, Animal; Buspirone; Exploratory Behavior; Haloperidol; Male; Mice; Mice, | 1994 |
Anxiogenic-like effects induced by stimulation of dopamine receptors.
Topics: Animals; Anxiety; Benzazepines; Carbolines; Dextroamphetamine; Diazepam; Dopamine Agents; Dopamine A | 1993 |
[A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine].
Topics: Adult; Antipsychotic Agents; Anxiety; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Chl | 1997 |
Possible toxic encephalopathy following high-dose intravenous haloperidol.
Topics: Antipsychotic Agents; Anxiety; Brain Diseases; Haloperidol; Humans; Male; Middle Aged | 1997 |
Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anxiety; Atropine; Bicuculline; | 1997 |
Effect of prenatal haloperidol administration on anxiety patterns in rats.
Topics: Animals; Antipsychotic Agents; Anxiety; Exploratory Behavior; Female; Haloperidol; Maze Learning; Pr | 1997 |
Sedation in the intensive care unit.
Topics: Analgesics, Opioid; Anesthetics, General; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Benzod | 1999 |
Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Behavior, Animal; | 2000 |
Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.
Topics: Animals; Anxiety; Behavior, Animal; Catalepsy; Corpus Striatum; Dopamine Agonists; Dopamine Antagoni | 2000 |
Abnormal age-related changes of plasma antioxidant proteins in schizophrenia.
Topics: Adolescent; Adult; Age Factors; Aging; Albumins; Antipsychotic Agents; Anxiety; Bilirubin; Depressio | 2000 |
Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Bro | 2001 |
A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Benzazepines; Brain; | 2001 |
The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Anxiety; Benzamides; Depression; Dopamine Antagonists; Female; Haloperi | 2001 |
Dysphoric response to neuroleptic treatment in schizophrenia: its relationship to autonomic arousal and prognosis.
Topics: Adult; Antipsychotic Agents; Anxiety; Arousal; Autonomic Nervous System; Basal Ganglia Diseases; Chl | 1979 |
Response of hemiballismus to haloperidol.
Topics: Aged; Anxiety; Diencephalon; Drug Evaluation; Haloperidol; Humans; Male; Movement Disorders | 1975 |
Intravenous tranquillization with ECT.
Topics: Adjustment Disorders; Adult; Aged; Amnesia, Retrograde; Anxiety; Depression; Diazepam; Electroconvul | 1975 |
Dementia induced by methyldopa with haloperidol.
Topics: Adult; Anxiety; Dementia; Drug Synergism; Haloperidol; Humans; Hypertension; Male; Methyldopa; Middl | 1976 |
Comparison of low doses of haloperidol and diazepam in anxiety states.
Topics: Anxiety; Diazepam; Haloperidol; Humans | 1976 |
[ICU syndrome].
Topics: Aged; Anxiety; Benzodiazepines; Clomipramine; Critical Care; Delirium; Depressive Disorder; Female; | 1991 |
A model to measure anticipatory anxiety in mice?
Topics: Animals; Anxiety; Body Temperature; Diazepam; Haloperidol; Imipramine; Male; Mice; Models, Psycholog | 1989 |
[Structure of the anxious-delusional syndrome of schizophrenic patients during treatment with anxiolytics].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Benzodiazepinones; Clozapine | 1986 |
Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome.
Topics: Animals; Antipsychotic Agents; Anxiety; Corpus Striatum; Defecation; Digestive System; Disease Model | 1987 |
Continuous subcutaneous infusion: flexible option in symptom control.
Topics: Anxiety; Female; Haloperidol; Humans; Infusion Pumps; Infusions, Parenteral; Metoclopramide; Middle | 1988 |
Presenile dementia: further experience with an anticoagulant-psychotherapy regimen.
Topics: Adult; Aged; Anticoagulants; Anxiety; Atrophy; Brain Diseases; Dementia; Dicumarol; Fear; Female; Ha | 1974 |
The clinical use of psychotherapeutic drugs in the elderly.
Topics: Aged; Aging; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety; Benzodiazepi | 1974 |
Tranquillizing effects of propranolol demonstrated in rats.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Anxiety; Atropine; Central Nervous Syste | 1971 |
Stuttering. An investigation of haloperidol.
Topics: Adolescent; Adult; Anxiety; Haloperidol; Humans; Orphenadrine; Stuttering; Trifluoperazine | 1973 |
Haloperidol in the treatment of anxiety-tension states.
Topics: Adolescent; Adult; Aged; Anxiety; Child; Female; Haloperidol; Humans; Male; Middle Aged | 1969 |
Haloperidol as a treatment of anxiety in psychoneurotic patients.
Topics: Adult; Aged; Anxiety; Anxiety Disorders; Female; Haloperidol; Humans; Male; Middle Aged; Premedicati | 1971 |
Comparison of haloperidol and fluphenazine in disturbed children.
Topics: Aggression; Anxiety; Autistic Disorder; Child; Child, Preschool; Female; Fluphenazine; Haloperidol; | 1970 |
[Features of a reaction to intravenous haloperidol administration].
Topics: Adult; Aggression; Alcoholism; Anxiety; Depression; Hallucinations; Haloperidol; Humans; Injections, | 1971 |
Haloperidol in low dosage in anxiety.
Topics: Adolescent; Adult; Aged; Anxiety; Female; Haloperidol; Humans; Male; Middle Aged | 1968 |
[On the pharmacological effects of an association of haloperidol and isopropamide bromide].
Topics: Anxiety; Depression; Female; Haloperidol; Humans; Male; Neurasthenia; Neurotic Disorders; Parasympat | 1966 |